Lessons Learned From Recent Cardiovascular Clinical Trials: Part II-Reference-Cited by-同舟云学术

Lessons Learned From Recent Cardiovascular Clinical Trials: Part II

Published:2002-08-13 Issue:7 Volume:106 Page:880-886
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

DeMets David L.¹,Califf Robert M.¹

Affiliation:

1. From the Duke Clinical Research Institute and the Division of Cardiology (R.M.C.), Duke University Medical Center, Durham, NC, and the Department of Biostatistics and Medical Informatics (D.L.D.), University of Wisconsin, Madison, Wis.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Organization, review, and administration of cooperative studies (greenberg report): A report from the heart special project committee to the National Advisory heart council, May 1967

2. Letter to the editors

3. Monitoring and Ensuring Safety During Clinical Research

4. Protecting Research Subjects — What Must Be Done

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases;International Journal of Molecular Sciences;2023-12-18

2. Protein kinases in cardiovascular diseases;Chinese Medical Journal;2022-02-02

3. A third trial oversight committee: Functions, benefits and issues;Clinical Trials;2019-10-30

4. Exploring the ethical and regulatory issues in pragmatic clinical trials;Clinical Trials;2015-09-15

5. Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry;American Heart Journal;2014-08